Schedule 13G ownership disclosure

CONCERT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 206022105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,396,003
Percent of class
4.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001041885-21-000005
Form type
SC 13G/A
Filer
CONCERT PHARMACEUTICALS, INC.
CIK
CIK 1367920
Filed
Feb 09, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub